2006, Number 6
<< Back Next >>
Rev Mex Neuroci 2006; 7 (6)
Prevention in neurology. Vascular brain disease
Olivares LL
Language: Spanish
References: 14
Page: 617-621
PDF size: 67.44 Kb.
ABSTRACT
From the theoretical point of view, it has been possible to reject the notion that apoplexy is a fortuitous phenomenon. This has been usefull for the brain vascular disease prevention, which seems very possible in any case that risk factors are well controlled. Appearance of apoplexy has a lot to do with conditioners that, combined or individually, are in charge to indicate which subjects are exposed to infarction or brain hemorrhage to which apoplexy is related. For prevention aims, it will be simple to induce the patient to control his arterial hypertension and take necessary medicines.
REFERENCES
Sacco RL, Elkind MS. Update on antiplatelet therapy for stroke prevention. Arch Intern Med 2000; 160(11): 1579-82.
Anon Cardiogenic brain embolism. The second report of the Cerebral embolism Task Force. Arch Neurol 1989; 46(7): 727-43.
Meacham RR, Headly S, Bronze M, Lewis JB, Roster MM. Impending paradoxical Embolism. Arch Inter Med 1998; 158: 438-48.
Oppenheimer SM, Lima J. Neurology and the heart. J Neurol Neurosur Psychiat 1998; 64: 289-307.
Anzola GP, Monanchi E, Casilli F, Onorato E. Different degrees of right to left shunting predict migraine and stroke: Data from 420 patients. Neurology 2006; 66: 765-7.
Bamford JD, Sandercock WC. Pronosis of transient ischemic attacks in the Oxfordshire Communit Stroke Project. Stroke 1990; 21: 848-53.
Baron JC, von Kummer, del Zopo GJ. Treatment of Acute Ischemic Stroke. Stroke 1995; 26: 2219-21.
Loublad KO, Laubadi HJ, Baird AB, CurtinF, Schlaug G, Edelman RR, et al. Clinical experience with diffusion-weighted MR in patients with acute stroke. Am J Neuroradiology 1998; 19(6): 1061-6.
Davenport RJ, Dennis MS, Wellwood BA, Warlow CP. Complications after acute stroke. Stroke 1996; 27: 415-20.
Lidegard O, Kreiner S. Contraceptives and cerebral thrombosis: a five-year national case control study. Contraception 2002; 65(3): 195-205.
Brey RL, Stallworth CL, Glasson MC. Antiphospholipid antibodies in stroke in young women. Stroke 2002; 33(10): 2400-1.
Girolami A, Zanon T, Zanardi S, Saracino MA, Simioni P. Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies. Blood Coagul Fibrinol 1996; 7(4): 497-501.
Roger XY, McNeil JJ, O’Malley HM, Davis SM, Thrift AG, Donnan GA. Risk factors for stroke due to cerebral infarction in young adults. Stroke 1997; 28: 1913-18.
Kirham FJ. Stroke in childhood. Arch Dis Child 1999; 81: 85-9.
Full text